• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Gastroenterology

Robotic approach to paraesophageal hernia repair associated with positive patient outcomes

byBrian DoughertyandAlex Chan
August 14, 2020
in Gastroenterology, Surgery
Reading Time: 2 mins read
Preoperative tumor embolization does not reduce operative blood loss
Share on FacebookShare on TwitterShare on LinkedIn

1. The use of robotic techniques to repair paraesophageal hernias resulted in low rates of recurrence and had positive patient outcomes at five years.

Evidence Rating Level: 3 (Average)

Since the advent of laparoscopic surgery in the 1980s, morbidity and mortality involving the repair of paraesophageal hernias (PEHs) has dramatically reduced. It is estimated, however, that the rate of recurrence of PEH is as high as 57% at some high-volume centers. Furthermore, PEH repair is one of the more demanding and technically challenging procedures in the foregut; thus, there is room for improvement in outcomes, in this instance with the use of robotic surgery. This prospective cohort study involved 233 patients (mean [SD] age = 67.8 [11.3] years, 66.1% female) who underwent either primary repair or secondary revision of a symptomatic PEH using a robotic surgery approach. Primary outcomes assessed serially over five years included the gastroesophageal reflux disease-health related quality of life questionnaire (GERD-HRQL) score, a standardized symptom questionnaire, and screening for recurrence with an esophagram. Five-year post-operative data were available for 145 (62%) patients. 70% of patients underwent primary repair while 30% underwent secondary revision. It was found that 13 of 145 patients experienced recurrence, with the most common residual symptoms being heartburn (12 of 145), bloating (11 of 145), and regurgitation (8 of 145). Average GERD-HRQL score was found to be significantly reduced when comparing pre-operative to five-year post-operative scores (25.6±8.7 vs. 4.5±1.7, 95% CI 19.7 to 22.5). Furthermore, between the pre-operative and the five-year post-operative cohorts, there were substantial reductions in occasional-to-daily anti-reflux medication usage (63.1% vs 13.8%, OR 0.094, 95% CI 0.054 to 0.161) and symptoms of dysphagia (11.2% vs. 2.8%, OR 0.224, 95% CI 0.076 to 0.652). Overall, this study suggested that robotic repair of PEHs is a safe, well-tolerated procedure with low rates of recurrence, results in a positive lifestyle impact among patients, and may represent a viable alternative to laparoscopic repair.

Click to read the study in JACS

Image: PD

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Induction with remimazolam (Byfavo) for patients undergoing laparoscopic gastrointestinal surgery may reduce post-operative delirium compared with propofol

Dexmedetomidine (Precedex) may offer similar analgesic efficacy as remifentanil (Ultiva) with fewer adverse effects in adults undergoing sleeve gastrectomy

Tags: Hernia Repairrobotic surgerySurgery
Previous Post

Nearly half of all HFrEF patients are not receiving therapy according to National guidelines, leading to poor outcomes

Next Post

#VisualAbstract: Serum antibody testing for SARS-CoV-2

RelatedReports

Two pieces of fabric showing stitching techniques with surgical tools in the foreground, indicating procedures for hernia repair.
Gastroenterology

Induction with remimazolam (Byfavo) for patients undergoing laparoscopic gastrointestinal surgery may reduce post-operative delirium compared with propofol

October 20, 2026
Robotic surgical instruments with surgical mesh and sutures, indicating a procedure for hernia repair.
Gastroenterology

Dexmedetomidine (Precedex) may offer similar analgesic efficacy as remifentanil (Ultiva) with fewer adverse effects in adults undergoing sleeve gastrectomy

October 6, 2026
A bag of enteral nutrition, a tube, and a graphic representation of the pancreas, suggesting early enteral nutrition in surgical patients.
Imaging and Intervention

Choice of bicarbonate-buffered solution versus compound sodium lactate as the intraoperative crystalloid solution during abdominal surgery remains unclear

September 15, 2026
A graphic featuring a heart, kidney, bladder, stethoscope, and an ultrasound machine, arranged in a flower-like design on a light blue background.
Weekly Rewinds

2 Minute Medicine Rewind September 14, 2026

September 14, 2026
Next Post
#VisualAbstract: Serum antibody testing for SARS-CoV-2

#VisualAbstract: Serum antibody testing for SARS-CoV-2

#VisualAbstract: Household transmissibility of SARS-CoV-2

#VisualAbstract: Household transmissibility of SARS-CoV-2

Large proportion of late preterm infants and older admitted to the NICU

2 Minute Medicine Rewind August 17, 2020

✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Tarlatamab plus durvalumab improved survival versus durvalumab alone in extensive-stage small cell lung cancer, Amgen reports in interim phase 3 results
  • Sacituzumab tirumotecan improved overall survival versus platinum chemotherapy in company-reported final phase 3 results
  • Camupepimut did not improve disease-free survival versus observation in pancreatic cancer in the randomized phase 2 AMPLIFY-7P trial
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.